LOCKHEED MARTIN CORP
LMT · NYSE · CIK 0000936468
SIC 3760
Guided Missiles & Space Vehicles & Parts
Category
Transportation Equipment
Entity
operating
Incorp.
MD
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Business Overview
Source: SEC 10-K3 ITEM 1A. Risk Factors 10 ITEM 1B. Unresolved Staff Comments 23 ITEM 1C. Cybersecurity 23 ITEM 2. Properties 24 ITEM 3. Legal Proceedings 25 ITEM 4. Mine Safety Disclosures 25 Information about our Executive Officers 25 PART II ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27 ITEM 6. [Reserved] 28 ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 29 ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk 49 ITEM 8. Financial Statements and Supplementary Data 50 ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 93 ITEM 9A. Controls and Procedures 93 ITEM 9B. Other Information 95 ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 95 PART III ITEM 10. Directors, Executive Officers and Corporate Governance 95 ITEM 11. Executive Compensation 95 ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 96 ITEM 13. Certain Relationships and Related Transactions, and Director Independence 96 ITEM 14. Principal Accounting Fees and Services 96 PART IV ITEM 15. Exhibits and Financial Statement Schedules 97 ITEM 16. Form 10-K Summary 101 SIGNATURES 102 Table of Contents PART I ITEM 1. Business General We are a global aerospace and defense technology company that builds and sustains the solutions America and its allies need to deter conflict and advance national security and scientific exploration objectives. Our four business areas – Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space – work as one company offering integrated solutions, at scale, across all warfighting domains. Our defense, space, intelligence, homeland security, information technology, and cybersecurity capabilities serve U.S. and international customers in defense, civil and commercial applications. Our principal customers are agencies of the U.S. Government and allies. Recent regional conflicts have demonstrated the integral role Lockheed Martin products play in protecting people, and we are rapidly transforming our business to meet increased demand. We are expanding production capacity to continue delivering at scale, and we are harnessing leading-edge technologies like artificial intelligence and autonomy, open-architecture systems, and advanced networking to make defense forces more agile, adaptive and unpredictable. Our goal is to deliver overwhelming capability and value – quickly, at the needed quantities and with the greatest effectiveness – to enable overmatch and strengthen deterrence today and into the future. We achieve this by developing and investing in differentiating technologies, forging strategic partnerships, including with commercial companies, executing on our multi-year business transformation initiative, maintaining fiscal discipline, and continuing to cultivate the greatest aerospace and defense workforce talent and culture in the world. We invest substantially in our people to ensure that our people have the technical skills necessary to succeed, and we expect to continue to invest internally in innovative technologies that address rapidly evolving mission requirements for our customers. We also will continue to evaluate our organizational structure and portfolio and will make strategic changes, acquisitions or divestitures, as appropriate, while deepening our connection to commercial industry through cooperative partnerships, joint ventures and equity investments. Business Segments We operate in four business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. We organize our business segments based on the nature of the products and services offered. Aeronautics Aeronautics is engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles and related technologies. Aeronautics also has contracts with the U.S. Government for various classified programs. Aeronautics' major programs include: • F-35 Lightning II – international multi-role, multi-variant, fifth generation stealth fighter. • C-130 Hercules – international tactical airlifter. • F-16 Fighting Falcon – combat-proven, international multi-role fighter. • F-22 Raptor – air dominance and multi-role fifth generation stealth fighter. The F-35 program is our largest program, generating 27% of our total consolidated sales, as well as 67% of Aeronautics' sales in 2025. The F-35 program consists of multiple development, production and sustainment contracts. Development is focused on modernizing F-35's capability and addressing emerging threats. Sustainment provides logistics and training support for the aircraft delivered to F-35 customers. Aircraft production is expected to continue well into the future gi
Investment Indicators
$565.62
+9.10 (+1.64%)
Open
$559.00
High
$569.96
Low
$556.45
Prev Close
$556.52
Volume
843,004
52W High
$692.00
52W Low
$401.93
50-day MA
$580.44
Quote as of: 2026-08-26
ROE
74.65%
Total Shareholder Yield
5.05%
Market Cap
$120.49B
P/E
25.50
P/B
16.21
PEG
1.11
EPS
20.49
BPS
32.56
Dividend Yield
2.56%
Beta
0.10
ROA
8.38%
D/E Ratio
7.90
Current Ratio
1.09
Gross Margin
10.15%
Operating Margin
10.30%
Net Margin
6.69%
Book Value/Share
$29.35
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$42.64B
Per-method implied market cap
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $27.54B | +337% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $42.64B | +183% |
Justified P/E 순이익 × 산업 평균 P/E | $75.25B | +60% |
P/B 배수 자본 × 산업 평균 P/B | $10.08B | +1095% |
P/S 배수 매출 × 산업 평균 P/S | $150.10B | -20% |
DCF (Gordon) CF × (1+g) / (r − g) | $95.08B | +27% |
DDM (Gordon) D × (1+g) / (r − g) | $34.79B | +246% |
▶Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +182.5% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 1 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +337.4%√(22.5 × 순이익 × 자본)
What it measures · Benjamin Graham's conservative safety-margin formula. A high value requires both earnings and equity to be solid, so read it as 'the ceiling for a financially intact company.'
How it is computed · √(22.5 × NetIncome × Equity). 22.5 = max P/E 15 × max P/B 1.5 Graham would pay. Net income is latest FY consolidated net income from DART/XBRL; equity is total equity from the same filing.
When to trust it · Best for stable profitable industrials. Underestimates SaaS/platform/biotech because intangible-heavy businesses carry little book equity.
Current
$120.49B
Implied fair
$27.54B
Gap (current − fair)
+$92.95B(+337.4%)
NetIncome = $5.02B Equity = $6.72B √(22.5 × $5.02B × $6.72B) = $27.54B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +182.5%순이익 × (8.5 + 2 × 성장률%)
What it measures · Graham's 1962 revision that bakes growth into the multiple. Unlike the static Graham Number, this scales linearly with EPS growth so growth stocks aren't punished as hard.
How it is computed · NetIncome × (8.5 + 2g). 8.5 = base P/E for a zero-growth firm; 2g = +2× P/E for every 1pp of EPS growth. g is YoY EPS growth, clamped to [-5%, +25%] so a single big year doesn't blow up the estimate.
When to trust it · Works for firms with proven, somewhat stable growth. Misleading for first-year profits, swing years, or any period where g is distorted by a one-time charge or gain.
Current
$120.49B
Implied fair
$42.64B
Gap (current − fair)
+$77.85B(+182.5%)
NetIncome = $5.02B Growth g = -6.0% → cap -5.0% Multiple = 8.5 + 2 × -5.0 = -1.5× $5.02B × -1.5 = $-7.53B
- EPS 성장률 -6.0%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 8.5x
Justified P/E
Overvalued +60.1%순이익 × 산업 평균 P/E
What it measures · Relative-value benchmark — "should trade at the industry average P/E." Not an absolute intrinsic value; tells you how the firm prices vs its peer set.
How it is computed · NetIncome × industry P/E. Defaults to a market-wide 15× when no industry multiple is provided. Net income is the latest FY consolidated net income.
When to trust it · Most reliable in mature industries with comparable peers (banks, telcos, utilities, refiners). Less useful for big-tech / hardware where industry P/Es span 10×–60×.
Current
$120.49B
Implied fair
$75.25B
Gap (current − fair)
+$45.24B(+60.1%)
NetIncome = $5.02B Industry P/E = 15× $5.02B × 15 = $75.25B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +1095.2%자본 × 산업 평균 P/B
What it measures · Multiplies book equity by industry P/B to imply a fair market cap. Best for asset-heavy businesses (banks, insurers, brokers, REITs) where balance-sheet value is the franchise.
How it is computed · Total Equity × industry P/B. Defaults to 1.5×. Equity is total equity (or parent-owners share) from the latest balance sheet.
When to trust it · Strongest for banks/insurers — asset-liability matching is the business. Materially under-prices SaaS, platforms, and brand-heavy businesses where intangible value dwarfs book equity.
Current
$120.49B
Implied fair
$10.08B
Gap (current − fair)
+$110.41B(+1095.2%)
Equity = $6.72B Industry P/B = 1.5× $6.72B × 1.5 = $10.08B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Undervalued -19.7%매출 × 산업 평균 P/S
What it measures · Multiplies revenue by industry P/S. Useful when earnings are negative or noisy (early-stage, restructuring) — revenue stays positive.
How it is computed · Revenue × industry P/S. Defaults to 2.0×. Revenue is the latest FY consolidated top line.
When to trust it · Ignores margin structure — a 30% operating margin business and a -5% one get the same multiple. Only meaningful within peer + margin cohort.
Current
$120.49B
Implied fair
$150.10B
Gap (current − fair)
$-29.61B(-19.7%)
Revenue = $75.05B Industry P/S = 2× $75.05B × 2 = $150.10B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +26.7%CF × (1+g) / (r − g)
What it measures · Simplified Gordon-growth DCF — discounting perpetual cash flows. Extremely sensitive to the cash-flow / discount-rate / growth-rate inputs; trust the scenario grid more than the headline number.
How it is computed · FCF × (1+g) / (r − g). FCF preferred from XBRL/DART; falls back to NetIncome, then 5% of Revenue (rough proxy). Discount rate r = risk-free (4%) + equity premium (5%) = 9%. Growth g is EPS YoY clamped to [-2%, +6%], default 3%.
When to trust it · Strongest for steady, predictable businesses. When r-g approaches 0, the denominator blows up; near-perpetuity-growth combos are intentionally voided. Useless for cyclicals (semis, commodities, shipping) where g itself is noise.
Current
$120.49B
Implied fair
$95.08B
Gap (current − fair)
+$25.41B(+26.7%)
FCF = $8.56B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $8.56B × (1 + -2.0%) / (9.0% − -2.0%) = $76.24B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DDM (Gordon)
Overvalued +246.3%D × (1+g) / (r − g)
What it measures · Values the firm purely on dividends paid to shareholders. Cleanest in theory, but only meaningful when management clearly intends to pay dividends — useless for share-repurchase-only payout policies.
How it is computed · D × (1+g) / (r − g). D from DART alotMatter (배당사항) or |CF dividendsPaid|. If absent, cascades to 30% of NetIncome (typical payout) → 30% of FCF → 1.5% of Revenue. r and g assumptions match DCF.
When to trust it · Most reliable for stable high-yielders (Korean utilities, tobacco, financial holdings). Sharply under-prices buyback-heavy firms (US big tech, parts of Korean IT) — look at the TSY column on the listing page to balance.
Current
$120.49B
Implied fair
$34.79B
Gap (current − fair)
+$85.70B(+246.3%)
Dividend D = $3.13B Discount r = 9.0% Growth g = -2.0% $3.13B × (1 + -2.0%) / (9.0% − -2.0%) = $27.89B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | -16.4% | -2.4% | +11.5% | +25.5% | +39.4% |
| 2% | -31.0% | -17.2% | -3.4% | +10.4% | +24.2% |
| 3% | -45.3% | -31.6% | -18.0% | -4.3% | +9.4% |
| 4% | -59.4% | -45.8% | -32.3% | -18.8% | -5.2% |
| 5% | -73.2% | -59.8% | -46.4% | -32.9% | -19.5% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +128.6% | +166.7% | +204.8% | +242.9% | +281.0% |
| 2% | +88.6% | +126.4% | +164.1% | +201.8% | +239.6% |
| 3% | +49.4% | +86.8% | +124.2% | +161.5% | +198.9% |
| 4% | +11.0% | +48.0% | +85.0% | +122.0% | +159.0% |
| 5% | -26.7% | +10.0% | +46.6% | +83.3% | +119.9% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Showing the latest 5 years only
17 years of financials are available for this stock. Unlock the remaining 12 years (10+ year history) with Pro.
Upgrade to Pro · $1.99/moIn USD millions (per-share figures shown directly) · Financials as of: 2026-01-29
핵심 지표 FY 2025
ROE
74.65%
총주주수익률
5.05%
PER
25.50
PBR
16.21
PSR
1.61
PEG
1.11
EV/EBITDA
14.40
배당수익률
2.56%
ROA
8.38%
부채비율
7.90
유동비율
1.09
매출총이익률
10.15%
영업이익률
10.30%
순이익률
6.69%
EPS
$20.49
BPS
$32.56
실적 추이
📄 SEC Filings
Quarterly Report
10-Q
2026-07-23
Open →
Current Report
8-K
2026-07-23
Open →
Current Report
8-K
2026-05-13
Open →
Quarterly Report
10-Q
2026-04-23
Open →
Current Report
8-K
2026-04-23
Open →
Proxy Statement
DEF 14A
2026-03-26
Open →
Annual Report
10-K
2026-01-29
Open →
Current Report
8-K
2026-01-29
Open →
Current Report
8-K
2025-12-18
Open →
Current Report
8-K
2025-12-09
Open →
Quarterly Report
10-Q
2025-10-21
Open →
Current Report
8-K
2025-10-21
Open →
Current Report
8-K
2025-08-29
Open →
Current Report
8-K
2025-07-28
Open →
Quarterly Report
10-Q
2025-07-22
Open →
Current Report
8-K
2025-07-22
Open →
Current Report
8-K
2025-05-09
Open →
Quarterly Report
10-Q
2025-04-22
Open →
Current Report
8-K
2025-04-22
Open →
Current Report
8-K
2025-04-17
Open →
Other filings (80)
Insider Transaction
xslF345X06/doc4.xml
2026-08-17
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-08-13
Open →
144
xsl144X01/primary_doc.xml
2026-08-13
Open →
144
xsl144X01/primary_doc.xml
2026-08-12
Open →
144
xsl144X01/primary_doc.xml
2026-08-11
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-08-04
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-07-02
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-07-02
Open →
11-K
11-K
2026-06-24
Open →
11-K
11-K
2026-06-24
Open →
11-K
11-K
2026-06-24
Open →
11-K
11-K
2026-06-24
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-06-15
Open →
3
xslF345X06/doc3.xml
2026-06-10
Open →
SD
SD
2026-05-27
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
S-3ASR
S-3ASR
2026-04-23
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-04-06
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-04-02
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-04-02
Open →
Insider Transaction
xslF345X06/doc4.xml
2026-04-02
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
ARS
ARS
2026-03-26
Open →
DEFA14A
DEFA14A
2026-03-26
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-03-13
Open →
144
xsl144X01/primary_doc.xml
2026-03-11
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-27
Open →
144
xsl144X01/primary_doc.xml
2026-02-27
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-24
Open →
144
xsl144X01/primary_doc.xml
2026-02-24
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-02-18
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-01-05
Open →
Insider Transaction
xslF345X05/doc4.xml
2026-01-05
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-12-09
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-12-09
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-12-09
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-12-09
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-12-09
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-10-28
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-10-27
Open →
144
xsl144X01/primary_doc.xml
2025-10-23
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-10-02
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-10-02
Open →
424B2
424B2
2025-07-24
Open →
FWP
FWP
2025-07-23
Open →
424B5
424B5
2025-07-23
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-07-02
Open →
Insider Transaction
xslF345X05/doc4.xml
2025-07-02
Open →
11-K
11-K
2025-06-24
Open →
11-K
11-K
2025-06-24
Open →
11-K
11-K
2025-06-24
Open →
11-K
11-K
2025-06-24
Open →
SD
SD
2025-05-28
Open →
PX14A6G
BOWYER RESEARCH - PX14A6G
2025-05-08
Open →
3
xslF345X02/doc3.xml
2025-04-25
Open →
DEFA14A
DEFA14A
2025-04-08
Open →